The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 01, 2020
Filed:
Mar. 20, 2018
Applicant:
New York University, New York, NY (US);
Inventors:
Michael D. Ward, New York, NY (US);
Zina Zhu, Elmhurst, NY (US);
Assignee:
New York University, New York, NY (US);
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07C 321/20 (2006.01); A61K 31/195 (2006.01); A61K 31/225 (2006.01); A61K 31/095 (2006.01); A61K 31/132 (2006.01); C07C 229/22 (2006.01); C07C 321/14 (2006.01); C07C 321/18 (2006.01);
U.S. Cl.
CPC ...
C07C 321/20 (2013.01); A61K 31/095 (2013.01); A61K 31/132 (2013.01); A61K 31/195 (2013.01); A61K 31/225 (2013.01); C07C 229/22 (2013.01); C07C 321/14 (2013.01); C07C 321/18 (2013.01);
Abstract
A method of preventing or inhibiting L-cystine crystallization is disclosed, using the compounds of formula I:R—[O]-(-A-L-)-A-[O]—R   Iwherein A, L, R, R, m, and v are as described herein. The compounds may be prepared as pharmaceutical compositions, and may be used for the prevention and treatment of conditions that are causally related to L-cystine crystallization, such as comprising (but not limited to) kidney stones.